Overweight

Use of weight loss medications appeared to be significantly lower among those from certain racial and ethnic minority groups, results from a cross-sectional study published in Journal of Racial and Ethnic Health Disparities revealed.

SAN ANTONIO — For Chinese adults with overweight or obesity, GLP-1 analog injections were safe and well tolerated, demonstrating robust body weight reductions and improved cardiometabolic parameters, researchers reported.

Compared with a low-fat diet, nutritional ketosis with or without exogenous ketones may positively impact self-reported menses for women, restarting or realigning menstrual cycles, according to study results published in PLOS ONE.

Vitamin D and calcium supplementation led to decreased blood pressure among older adults with overweight, especially those with obesity and hypertension, according to a post hoc analysis published in Journal of the Endocrine Society.

SAN ANTONIO — Due to structural barriers such as low income and inadequate insurance coverage, Black and Hispanic adults were more likely to ration prescription drugs to save money, researchers reported.

SAN ANTONIO — At 24 months, children who received a health literacy-informed digital text and web-based intervention had better weight trajectories vs. those who did not, according to Greenlight Plus Trial results presented at ObesityWeek.

BOSTON — In a survey, cardiology physicians expressed hesitancy to prescribe currently available obesity medications, preferring exercise and dietary interventions, but with little personalized tailoring for patients, researchers reported.

A novel oral GLP-1 receptor agonist was well-tolerated and linked with weight loss compared with placebo in healthy adults with overweight or obesity, according to top-line results of a phase 1 study.

People with excess adiposity in young adulthood were more likely to have adverse cardiac structure and function later in life compared with people without it, researchers reported in the European Heart Journal.